AI English summary of an SEC filing — figures as filed

The company said net sales for Q3 rose 4.6% to $5,369 million, and organic sales grew 3.6%. Organic sales include a 0.2% negative impact from lower private label pet food sales.

8-KResults of Operations and Financial ConditionFiled Oct 30, 2026Period of report Oct 30, 2026Summary published (UTC) Oct 30, 2026

Key points

AI summary

The company said net sales for Q3 rose 4.6% to $5,369 million, and organic sales grew 3.6%. Organic sales include a 0.2% negative impact from lower private label pet food sales.
Colgate-Palmolive said GAAP diluted earnings per share for Q3 rose 3% to $0.94, and Base Business EPS increased 7% to $0.97. It said GAAP gross profit margin rose 80 basis points to 60.2%.
The company said net sales for Q3 were +12.5% in Latin America and +5.6% in Hill's Pet Nutrition, while North America was -1.7%. Operating profit was $392 million in Latin America (+17%) and $177 million in North America (-11%).
The company said it expects net sales for full-year 2026 to rise 4% to 5%, versus its prior outlook of 2% to 6%. It now expects Base Business EPS growth of 5% to 7%. Operating cash flow for the 9 months was $2,913 million.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Colgate-Palmolive Q3 net sales $5,369 million, organic sales up 3.6%

The company said net sales for Q3 rose 4.6% to $5,369 million, and organic sales grew 3.6%. Organic sales include a 0.2% negative impact from lower private label pet food sales.

Source · Based on the filing body and exhibits

The company's Q3 GAAP EPS $0.94, Base Business EPS $0.97

Colgate-Palmolive said GAAP diluted earnings per share for Q3 rose 3% to $0.94, and Base Business EPS increased 7% to $0.97. It said GAAP gross profit margin rose 80 basis points to 60.2%.

Source · Based on the filing body and exhibits

Net sales growth and operating profit by division for Q3

The company said net sales for Q3 were +12.5% in Latin America and +5.6% in Hill's Pet Nutrition, while North America was -1.7%. Operating profit was $392 million in Latin America (+17%) and $177 million in North America (-11%).

Source · Based on the filing body and exhibits

Full-year 2026 outlook revised and 9-month cash flow

The company said it expects net sales for full-year 2026 to rise 4% to 5%, versus its prior outlook of 2% to 6%. It now expects Base Business EPS growth of 5% to 7%. Operating cash flow for the 9 months was $2,913 million.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.